Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May 13:10:3519-31.
doi: 10.2147/IJN.S80502. eCollection 2015.

Functionalized self-assembling peptide improves INS-1 β-cell function and proliferation via the integrin/FAK/ERK/cyclin pathway

Affiliations

Functionalized self-assembling peptide improves INS-1 β-cell function and proliferation via the integrin/FAK/ERK/cyclin pathway

Jingping Liu et al. Int J Nanomedicine. .

Abstract

Islet transplantation is considered to be a curative treatment for type 1 diabetes mellitus. However, disruption of the extracellular matrix (ECM) leads to β-cell destruction and graft dysfunction. In this study, we developed a functionalized self-assembling peptide, KLD-F, with ECM mimic motifs derived from fibronectin and collagen IV, and evaluated its effect on β-cell function and proliferation. Atomic force microscopy and rheological results showed that KLD-F could self-assemble into a nanofibrous scaffold and change into a hydrogel in physiological saline condition. In a three-dimensional cell culture model, KLD-F improved ECM remodeling and cell-cell adhesion of INS-1 β-cells by upregulation of E-cadherin, fibronectin, and collagen IV. KLD-F also enhanced glucose-stimulated insulin secretion and expression of β-cell function genes, including Glut2, Ins1, MafA, and Pdx-1 in INS-1 cells. Moreover, KLD-F promoted proliferation of INS-1 β-cells and upregulated Ki67 expression by mediating cell cycle progression. In addition, KLD-F improved β-cell function and proliferation via an integrin/focal adhesion kinase/extracellular signal-regulated kinase/cyclin D pathway. This study highlights the fact that the β-cell-ECM interaction reestablished with this functionalized self-assembling peptide is a promising method to improve the therapeutic efficacy of islet transplantation.

Keywords: extracellular matrix; insulin secretion; islet transplantation; self-assembling peptide; β-cell proliferation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Molecular design and characteristics of functionalized self-assembling peptide. Notes: (A) Design and synthesis of KLD-F with FN and collagen IV mimic motifs, with KLD-F self-assembling into a nanoscale scaffold for encapsulating INS-1 β-cell. (B) Atomic force micrographs of KLD12 and KLD-F (0.1 mg/mL, bar 500 nm). (C) Width and height of KLD and KLD-F nanofibers (*P<0.05). (D) Photograph of KLD-F solution and hydrogel (10 mg/mL). (E) Rheological properties of KLD-F solution and hydrogel (Pa). Abbreviations: ECM, extracellular matrix; FN, fibronectin.
Figure 2
Figure 2
Functionalized self-assembling peptide enhanced ECM remodeling and cell-cell adhesion in INS-1 β-cells. Notes: (A) Light and immunofluorescent micrographs of E-cad, FN, and Coll IV (bar 50 μm) after 3 days of culture. (B) Real-time polymerase chain reaction analysis of E-cad, FN, and Coll IV mRNA expression after 3 days of culture. (C) Western blot and quantitative analysis of E-cad and FN protein expression after 3 days of culture (*P<0.05). Abbreviations: FN, fibronectin; E-cad, E-cadherin; Coll IV, collagen IV.
Figure 3
Figure 3
Functionalized self-assembling peptide improved insulin secretion function in INS-1 β-cells. Notes: (A) Insulin secretion, (B) intracellular insulin (under 20 mM glucose), and (C) GSIS index in the different groups after 3 days of culture. (D) Real-time polymerase chain reaction analysis of Glut2, Ins1, MfaA, and Pdx-1 mRNA expression after 3 days of culture. (E) Immunofluorescent staining for insulin (under 20 mM glucose condition) and Pdx-1 (bar 50 μm). (F) Western blot and quantitative analysis of PDX-1 protein level after 3 days of culture (*P<0.05). Abbreviations: DAPI, 4,6-diamidino-2-phenyllindile; GSIS, glucose-stimulated insulin secretion; Glu, glucose.
Figure 4
Figure 4
Functionalized self-assembling peptide promoted cell proliferation in INS-1 β-cells. Notes: (A) Cell proliferation rates detected by CCK-8 assay after 3 days of culture. (B) BrdU enzyme-linked immunosorbent assay of INS-1 cell proliferation after 3 days of culture. (C) Glucose consumption rates (%) in different groups after 3 days of culture. (D) Western blot and quantitative analysis of Ki67 protein expression after 3 days of culture. (E) Immunofluorescent staining of Ki67 (bar 50 μm) and quantitative analysis of Ki67-positive cells (*P<0.05). Abbreviations: CCK-8, Cell Counting Kit-8; DAPI, 4,6-diamidino-2-phenyllindile; ELISA, enzyme-linked immunosorbent assay.
Figure 5
Figure 5
Functionalized self-assembling peptide induced cell cycle progression in INS-1 β-cells. Notes: (A) Flow cytometry analysis of cell cycle. (B) G1, S, and G2/M phase distribution after 3 days of culture. (C) Proliferation index and (D) S-phase cell fraction detected by flow cytometry (*P<0.05). (E) Real-time polymerase chain reaction analysis of Ccnd1, Ccne1, Cdk2, and Cdkn1a mRNA levels after 3 days of culture (*P<0.05).
Figure 6
Figure 6
Mechanism of functionalized self-assembling peptide inducing β-cell proliferation. Notes: (AC) Western blot for p-FAK/FAK, p-Akt/Akt, and p-ERK/ERK after 1 day of culture, and quantitative analysis of protein level. (DF) Western blot for integrin α5 and β1, cyclin D1, and p21 after 1 day of culture, and quantitative analysis of protein level (*P<0.05, **P<0.01). (G) Schematic map of signaling pathways. KLD-F binds to integrin α5 and β1, subsequently activating FAK/ERK and downstream cyclin D1 as well as inhibiting p27 signaling, finally promoting β-cell proliferation. Abbreviations: ECM, extracellular matrix; FAK, focal adhesion kinase; ERK, extracellular signal-regulated kinase.

Similar articles

Cited by

References

    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;S1:S55–S60. - PubMed
    1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–1625. - PubMed
    1. Liu J, Wang D, Chen Y, et al. 1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy. Mol Biosyst. 2013;9:2645–2652. - PubMed
    1. Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes. 2014;7:211–223. - PMC - PubMed
    1. Korsgren O, Lundgren T, Felldin M, et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia. 2008;51:227–232. - PubMed

Publication types

MeSH terms